To guide anesthetic administration with electroencephalogram monitors in children, an adequate characterization of the anesthetic effect measured by these monitors in this population is needed. We sought to quantify and compare the dynamic profile of sevoflurane's effect measured with the cerebral state index (CSI) and the bispectral index (BIS) in children. METHODS: Fifteen healthy children, aged 3-15 yr, scheduled to undergo minor surgery were prospectively studied. During the simultaneous recording of CSI and BIS, the sevoflurane vaporizer was set at 6 vol % for 5 min and then decreased. End-tidal concentrations (C ET ) were measured. The C ET -sevoflurane effect-site concentration equilibration and pharmacodynamics were modeled. Goodness of fit between models was compared. Data are typical value (coefficient of variation). RESULTS: Within the anesthetic depth range studied, the rate of change of sevoflurane's effect expressed as the effect-site equilibration half-life (t 1/2 k e0 ) was slower with the CSI [2.0 (14) min] than with BIS [1.2 (53) min] (P Ͻ 0.05). The estimated baseline effect of BIS and CSI before sevoflurane administration (E 0 ) was 84 (39) for CSI and 87 (7) for BIS (NS). The sensitivity to sevoflurane hypnotic effect expressed in the C 50 [steady-state C ET eliciting half of the maximum response (E max )] was 2.1 (68) % with CSI and 2.1 (16)% with BIS (NS). The E max with CSI 45 (0) was higher than that with BIS 27 (39) (P Ͻ 0.05). The population prediction error was significantly better for BIS (Ϫ0.7 Ϯ 26.9) than for CSI (Ϫ3.0 Ϯ 178.6) (P Ͻ 0.05). CONCLUSIONS: In children, the t 1/2 k e0 of sevoflurane and the pharmacodynamics of sevoflurane were quantified and the results were entirely dependent on the monitor used to measure its hypnotic effect. Within the anesthetic depth range studied, the rate of change of sevoflurane's effect was slower with the CSI. To adequately guide sevoflurane administration with these monitors in children, these differences should be considered.
Thebi spectral index (BIS) monitor (Aspect Medical
Systems, Newton, MA) and the cerebral state monitor (CSM Danmeter A/S, Odense, Denmark) are electroencephalogram (EEG) devices that have been used to guide anesthetic administration in children. [1] [2] [3] [4] Using their own algorithms, 5, 6 which were derived from adult EEG data, these monitors calculate indices that can range from 100 (fully awake) to 0 (isoelectric EEG). Different EEG monitors have been shown to behave differently under similar anesthetic conditions. 7, 8 Therefore, an adequate characterization of the effect measured by each device is mandatory before using them as tools to guide anesthetic administration. This effect can be studied during nonsteady-state conditions through the application of an effect compartment model. 9 With this approach, it is possible to characterize both the effect-site concentration (Ce) versus effect relationship and the speed of onset and offset of the anesthetic action measured with these monitors.
Sevoflurane is the most frequently used inhaled anesthetic for induction of anesthesia in children. The aim of this study is to quantify and compare the dynamic profile of sevoflurane's effect measured with the cerebral state index (CSI) calculated by the CSM and BIS in children.
METHODS
After local ethics committee approval (Facultad de Medicina, Pontificia Universidad Cató lica, Santiago, Chile), informed written consent was obtained from the parents of all patients. Fifteen ASA I children, aged 3-15 yr, were prospectively studied from December 2006 to March 2007. All patients were scheduled to undergo elective surgery under general anesthesia and did not receive any premedication. Exclusion criteria were any known central nervous system disease, recent administration (48 h) of any drug acting in the central nervous system, and any known adverse effect to the study drug.
In the operating room, standard monitoring was applied. At this time, the pediatric sensors of the Aspect A-2000 BIS ® monitor (version XP) and the standard electrodes of the CSM model 2 monitor were placed on each patient according to the manufacturers' recommendations. The smoothing time period of the BIS monitor was set at 15 s. BIS values were automatically recorded and transferred to computer hard disk for off-line analysis using the Hyperterminal (Microsoft, Redmond, VA) program. The CSM updates the CSI every 1 s and has a fixed smoothing time of around 10 s. 10 The CSI data were recorded using the Danmeter A/S CSM capture V2.02 onto the computer hard disk. The BIS and the CSI were recorded simultaneously during the study period.
The Datex Capnomac monitor (GE Healthcare, Helsinski, Finland) was used to measure sevoflurane end-tidal concentrations (C Etsevo ). Measurements were automatically registered every 10 s throughout the study period and transferred to computer hard disk using the software program Hyperterminal (Microsoft).
Before sevoflurane administration, a 1-min baseline period was recorded. During this period, patients were kept undisturbed and spontaneously breathing through a facemask. During the transition period, fresh gas flow (100% oxygen) was maintained at 5 L/min, the mask was manually sealed as tight as possible, and ventilation was assisted to maintain end-tidal carbon dioxide concentrations between 30 and 35 mm Hg. The sevoflurane vaporizer was turned to 6% for 5 min or until burst suppression (BS) Ն80%. Immediately after, the vaporizer was turned-off until BIS returned to values Ͼ60. At this point, the study was finished and anesthesia continued according to the anesthesiologist's criteria.
Before starting the recording of CSI and BIS data, the time of both monitors was synchronized. Pairwise CSI and BIS data obtained every 5 s was used in the subsequent analysis. The baseline awake BIS and CSI values (mean Ϯ sd) were calculated using data recorded before sevoflurane administration. The data were judged adequate for baseline calculations if the signal quality index of BIS and CSI was Ͼ20% for 30 s.
To study the relationship between sevoflurane concentrations in the effect compartment (Ce sevo ) and the corresponding BIS or CSI values, it was assumed that C ETsevo reflected its plasma concentration (Cp) and that Ce sevo was linearly linked to Cp. Ce sevo was estimated as:
where the k e0 is the first-order C ETsevo versus Ce sevo equilibration rate constant. The Ce over time were calculated as the convolution of the predicted plasma concentrations over time with the disposition function of the effect site. The convolution was based on a "connect the dots" approach, previously used by Schnider et al. 11 The k e0 was estimated by minimizing the area of the hysteresis loop of either EEG index data versus Ce sevo . The mathematical approach can be found elsewhere. 12 The relation between Ce sevo and BIS or CSI was modeled using a sigmoidal E max model:
where effect is the measured BIS or CSI value, E 0 is the baseline measurement when no drug is present, E max is the maximum possible drug effect, Ce sevo is the calculated effect-site concentration of sevoflurane, Ce 50sevo is the effect-site concentration associated with 50% maximal drug effect, and ␥ is the steepness of the concentration-response relation curve. The model parameters were estimated using NONMEM V (Globomax LLC, Hanover, MD).
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Interindividual variability was assumed to have a log-normal distribution:
where P i is the parameter value (K e0 , E 0 , E max , ␥, or Ce 50 ) in the ith patient, P tv is the typical value of the parameter in the population, and is a random variable with a mean of 0 and a variance of 2 . Individual variability is reported as , the sd of in the log domain, which is approximately the coefficient of variance in the standard domain. Residual intraindividual variability was modeled using a standard additive error model.
The goodness of the model fit was evaluated. We calculated the population prediction error (PE) between the observed values and post hoc Bayes predicted values for BIS and CSI and the absolute median prediction error (MDAPE) for each patient.
14 Differences between both indices for PE and MDAPE were tested using a Student's t-test.
Normality of data was tested with the KolmogorovSmirnov test. Comparisons between monitors were performed with paired Student's t-test or Wilcoxon's signed rank test. A P value Ͻ0.05 was considered statistically significant. Statistical analyses were performed using R (language and environment for statistical computing, freely available from http://www. r-project.org/). Data are mean Ϯ sd (range) or typical value (coefficient of variation).
RESULTS
All patients, 7 female and 8 male, age 8.1 Ϯ 3.6 (3.6 -15.0), weight 35.3 Ϯ 15.9, (16 -65), and height 131 Ϯ 23 (97-168), completed the study. No conflict in the positioning of the two sensors was observed. Adequate airway management was obtained in all patients without requiring insertion of an oral airway. Peripheral oxygen saturation was maintained above 95% throughout the study period in all children.
Measured awake BIS and CSI values were 91.7 Ϯ 4.4 and 89.2 Ϯ 10.4, respectively (NS). Awake CSI values ranged from 100 to 63 showing a wider dispersion than BIS (98 -80). During the baseline period, the maximum levels of electromyographic (EMG) activity were recorded in both monitors, CSM (96% Ϯ 10%) and BIS (48% Ϯ 3%) (P Ͻ 0.05). The signal quality index was Ͼ20% in both monitors during this period. The minimum BIS and CSI values observed during the study period were 10.8 Ϯ 5.8 and 36.9 Ϯ 1.1, respectively (P Ͻ 0.05). No BS activity was recorded by the BIS or CSI monitors throughout the study period. Figure 1 shows the time course of BIS, CSI, and C ETsevo for each patient. The hysteresis loop between BIS, CSI, and C ETsevo is shown in Figure 2. A sigmoid E max model could be fitted to the data of all patients. The rate of change of sevoflurane's effect expressed as the t 1/2 k e0 was slower with the CSI Table  1 . We were unable to estimate the variance for some of the parameters. The residual error for each model (as a measure of the intraindividual variability in the log domain) was 9.45 for BIS and 11.05 for CSI. The relations between the observed and the post hoc Bayesian predicted BIS and CSI versus Ce sevo are plotted in Figures 3 and 4 . With increasing Ce sevo , both BIS and CSI decreased.
The goodness of the model fit was first analyzed by observing the relation between observed and post hoc Bayesian predicted values of BIS and CSI. As observed in Figure 5 , a smaller scatter was observed for BIS than for CSI. The population PE was significantly better for BIS (Ϫ0.71 Ϯ 26.9) than for CSI (Ϫ2.95 Ϯ 178.62) (P Ͻ 0.05). The MDAPE for BIS (12.09 Ϯ 4.47) and for CSI (14.10 ϩ 4.87) were similar (P ϭ 0.24).
DISCUSSION
This study quantified and compared the relationship between C ETsevo and BIS or CSI during sevoflurane anesthesia in children. The major finding of this study is that the parameters of the pharmacokinetic and pharmacodynamic model were entirely dependent on the monitor used to measure sevoflurane's effect. The t 1/2 k e0 in this study not only represents sevoflurane's end-tidal to brain equilibration time, but also the time delay of the index used to measure sevoflurane's effect. In a study using simulated EEG signals, Pilge et al. 15 showed that all currently available EEG indices had different time lags to react to a change in the level of anesthesia. The authors also showed that these delays were not constant, and that they varied depending on the depth of anesthetic level and on whether this level was increasing or decreasing. The response measured by these monitors and the computational delays involved in the calculation of the corresponding EEG indices will influence the t 1/2 k e0. In the present study, the lower t 1/2 k e0 estimated with BIS indicated faster on and offset times for the response measured with this monitor compared with the response measured by the CSM. This finding is consistent with Pilge et al.'s results, where time delays of BIS tended to be shorter than CSI delays when intermediate ranges of anesthetic depth were simulated. 15 The Ce versus effect relationship for sevoflurane was also found to be influenced by the monitor used to measure its hypnotic effect. Although BIS and CSI are both ordinal scales, these variables were treated as continuous data in the model analysis. This assumes that changes in these indices represent a relative change in the magnitude of hypnosis. Both indices showed similar awake values with a wider dispersion observed in the CSI. With this last index, values indicative of sedation were observed in some patients before sevoflurane administration. Both BIS and CSI then progressively decreased during sevoflurane induction (Fig. 1) . However, BIS showed a more pronounced and less variable decrease compared with CSI ( Figs. 3 and 4 , respectively). At deeper anesthetic levels (Ce sevo Ͼ3%), both indices tended to stabilize, but BIS reached lower E max values than CSI, which showed a plateau around 40. This plateau might be explained because the CSI does not include frequencies below 6 Hz in its algorithm. 6 Therefore, ␦ waves, typically present during deep anesthesia, are not detected by the CSI, leading to poor correlation with the Ce sevo until BS is observed. This is particularly the case in this study, as no BS was observed. It has been shown that the CSI can decrease below 40 if BS is registered but is very unlikely to do so if no BS is observed. 6, 8 EMG activity can contaminate EEG signals and might alter the value of EEG-derived indices. In our study, high levels of EMG activity were recorded during the baseline period and at the beginning of the induction period. The wide range of CSI values observed during baseline and during light anesthesia suggests that this index is highly affected by EMG activity. In addition, there is a new pediatric BIS sensor with four electrodes (not used in the current study) that is supposed to better detect and discard artifacts in the signal, improving the performance of this monitor, especially during light anesthesia.
Since BIS is currently considered a useful tool to guide anesthetic doses in children Ͼ1 yr, 1 we decided to include a broad age range to increase the general applicability of our results. It can be argued that the age range chosen was too wide and that age changes in EEG might be influencing our results. 16 However, it has been described that awake BIS values in children between 1 and 15 yr are close to values reported in adult patients and that the BIS response during emergence from sevoflurane anesthesia is also relatively similar to that reported in adult studies. 17 Another limitation of this study is that clinical variables of consciousness were not incorporated in the analysis. However, the relatively long and variable time delays of all currently available EEG monitors 15 limit the applicability of these variables as markers of imminent loss of consciousness when rapid infusion schemes of anesthetics are used. 18 We think that to reliably assess clinical end-points and to correlate them with the corresponding EEG index or Ce, slower induction rates or steady-state designs are more adequate.
Advisory systems for sevoflurane administration have been assessed in adult patients showing an improvement in the titration of this drug. 19 Some future development of an on-line available pharmacodynamic model derived from our results in children might be useful to guide drug administration in this population. However, differences in the measured response by these monitors should be considered.
CONCLUSIONS
In children, the t 1/2 k e0 of sevoflurane and the pharmacodynamics of sevoflurane were quantified and the results entirely depended on the monitor used to measure its hypnotic effect. Within the anesthetic depth range studied, the rate of change of sevoflurane's effect was slower with the CSI. To adequately guide sevoflurane administration with these monitors in children, these differences should be considered.
